Volume 14, Issue 1 | Fall 2007 |
|---|---|
| [Masthead] | Articles |
| Pharmaceutical Lemons: Innovation and Regulation in the Drug Industry | Ariel Katz |
| Restoring the Genetic Commons: A "Common Sense" Approach to Biotechnology Patents in the Wake of KSR v. Teleflex | Anna Bartow Laakmann |
| Software Development as an Antitrust Remedy: Lessons from the Enforcement of the Microsoft Communications Protocol Licensing Requirement | William H. Page Seldon J. Childers |
| "Justice, and Only Justice, You Shall Pursue": Network Neutrality, the First Amendment and John Rawls's Theory of Justice | Amit M. Schejter Moran Yemini | Comment |
| The Patent End Game: Evaluating Generic Entry into a Blockbuster Pharmaceutical Market in the Absence of FDA Incentives | Jeremiah Helm | Notes |
| Copyright and YouTube: Pirate's Playground or Fair Use Forum? | Kurt Hunt |
| The FCC Complaint Process and "Increasing Public Unease": Toward an Apolitical Broadcast Indecency Regime | Kurt Hunt |
| FDA Approval of Generic Biologics: Finding a Regulatory Pathway | Kathleen R. Kelleher |
Volume 14, Issue 2 | Spring 2008 |
|---|---|
| [Masthead] | Articles |
| The General Public License Version 3.0: Making or Breaking the Foss Movement? | Clark D. Asay |
| E-Contract Doctrine 2.0: Standard Form Contracting in the Age of Online User Participation | Shmuel I. Becher Tal Z. Zarsky |
| Research Tool Patents After Integra v. Merck—Have They Reached a Safe Harbor? | Wolrad Prinz zu Waldeck und Pyrmont | Notes |
| Synopsis of the Extraterritorial Protection Afforded by Section 337 as Compared to the Patent Act | Neil F. DuChez |
| A New Frontier or Merely a New Medium? An Analysis of the Ethics of Blawgs | Justin Krypel |
